Risk for SARS-CoV-2 infection in patients with breast cancer treated with chemotherapy, biologic therapy or active surveillance: Patient outcomes from multicenter institution in New York.

被引：4

作者：

Budhathoki, Nibash

Kucharczyk, John

D'Abreo, Nina

Kwa, Maryann J.

Plasilova, Magdalena

Dhage, Shubhada

Hindenburg, Alexander A.

Lee, Joanna

Winner, Megan

Daly, Alison

Soe, Phyu Phyu

Ramdhanny, Angela

Schnabel, Freya Ruth

Oratz, Ruth

Speyer, James L.

Novik, Yelena

Meyers, Marleen Iva

Jones, Simon

Adams, Sylvia

Marks, Douglas Kanter

机构：

[1] NYU, Langone Hosp Long Isl, Perlmutter Canc Ctr, Mineola, NY USA

[2] NYU, Langone Hosp Long Isl, Mineola, NY USA

[3] NYU, Langone Hosp Long Isl, Long Isl Sch Med, Perlmutter Canc Ctr, Mineola, NY USA

[4] NYU, Canc Inst, New York, NY USA

[5] NYU, Langone Hosp Brooklyn, Brooklyn, NY USA

[6] NYU, Langone Med Ctr, Bellevue Hosp, New York, NY USA

[7] NYU, Winthrop Hosp, Mineola, NY USA

[8] NYU, Langone Hosp Long Isl, Long Isl Sch Med, Perlmutter Canc Ctr,Dept Med,Div Oncol Hematol, Mineola, NY USA

[9] NYU, Langone Hlth, New York, NY USA

[10] NYU, Dept Populat Hlth, New York, NY USA

来源：

关键词：

D O I：

10.1200/JCO.2021.39.15_suppl.1513

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1513

引用

页数：4